Desogestrel
Lemena is used to prevent pregnancy.
The tablets contain a small amount of the female sex hormone, progestogen, called desogestrel. For this reason, Lemena is also called a progestogen-only pill or mini-pill. Unlike combined contraceptive pills, mini-pills do not contain estrogen, the other female sex hormone.
The way most mini-pills work is mainly by stopping sperm from entering the cervix. Unlike combined contraceptives, they do not always prevent the release of an egg from the ovary. Lemena is different from other mini-pills in that, like combined contraceptives, it usually prevents the release of an egg from the ovary. As a result, Lemena is a very effective contraceptive.
Unlike combined pills, it can be used by women who cannot tolerate estrogens and by breastfeeding women. The biggest inconvenience when taking Lemena may be irregular bleeding. Bleeding may also not occur at all.
The chance of becoming pregnant while taking Lemena, provided you have taken the tablets correctly and have not missed any, is very low.
Like other hormonal contraceptives, Lemena does not protect against HIV (AIDS) or other sexually transmitted diseases.
Do not take Lemena if you have any of the conditions listed below. If you have any of these conditions, tell your doctor before taking Lemena. Your doctor may recommend a non-hormonal method of contraception.
If any of these conditions occur for the first time while taking Lemena, you should contact your doctor immediately.
When taking Lemena in any of the following situations, close medical supervision is required.
Before taking Lemena, discuss this with your doctor:
If you take Lemena in any of these situations, you may need close monitoring. Your doctor will explain how to proceed.
Some women taking hormonal contraceptives, including Lemena, have reported depression or mood swings. Depression can be severe and sometimes lead to suicidal thoughts. If you experience mood changes and symptoms of depression, you should contact your doctor as soon as possible for further medical advice.
Estrogens play an important role in maintaining normal bone mass. During treatment with Lemena, the level of natural estrogen (estradiol) in the blood is comparable to that in the first half of a woman's natural cycle, but lower than in the second half of the natural cycle. It is not known whether this has any effect on bone mass.
Every woman is at risk of breast cancer, whether or not she is taking contraceptive pills. Breast cancer is more common in women taking contraceptive pills than in women of the same age who are not taking them. After stopping the pill, the risk gradually decreases, and after 10 years of stopping the pill, it is the same as for women who have never taken the pill. Breast cancer is less common in women under 40, but the risk increases with age. Therefore, more cases of breast cancer are diagnosed in women taking contraceptive pills at an older age. The length of time you take the pill does not seem to be important.
For every 10,000 women taking the pill for up to 5 years, from age 16 to 20, there is less than 1 extra case of breast cancer in the next 10 years compared to 4 cases of breast cancer normally diagnosed in this age group. Similarly, for every 10,000 women taking the pill for up to 5 years, from age 20 to 30, there are 5 extra cases of breast cancer compared to 44 cases normally diagnosed in this age group. For every 10,000 women taking the pill for up to 5 years, from age 30 to 40, there are 20 extra cases of breast cancer compared to 160 cases normally diagnosed in this age group.
The risk of breast cancer in women taking progestogen-only pills, such as Lemena, is similar to that in women taking combined pills, but the data are not conclusive.
It appears that in women taking contraceptive pills, breast cancer is usually less advanced than in women who do not take the pill.
It is not known whether this difference is caused by the pill. The reason may be earlier detection of breast cancer, as women taking the pill are more likely to have regular check-ups.
Venous thromboembolic disease is a condition where a blood clot forms, which can block a blood vessel. Sometimes it can occur in the deep veins of the legs (deep vein thrombosis). If the clot breaks loose from where it formed, it can travel to the lungs and block a pulmonary artery, forming a pulmonary embolism. This can lead to death. Venous thromboembolic disease is very rare. It can also occur if you are not taking contraceptive pills. It can also occur during pregnancy. The risk of venous thromboembolic disease is higher in women taking contraceptive pills than in those who are not taking them. It is thought that the risk of venous thromboembolic disease in women taking progestogen-only pills, such as Lemena, is lower than in women taking combined contraceptive pills that contain estrogen.
There are no available clinical data on the efficacy and safety of Lemena in adolescents under 18 years of age.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take, including herbal medicines and medicines obtained without a prescription.
Some medicines may interfere with the proper functioning of Lemena. This applies to medicines used to:
Your doctor will advise whether you need to use additional contraceptive methods, and if so, for how long.
Lemena may also affect the action of other medicines, making them stronger (e.g., cyclosporine) or weaker.
While taking Lemena, vaginal bleeding may occur irregularly. This may be light spotting or heavy bleeding. Bleeding may also not occur at all.
Irregular bleeding does not mean that the contraceptive effect of Lemena is reduced. Usually, no action is needed, and you should continue taking Lemena. You should contact your doctor if the bleeding is very heavy and prolonged.
During the use of all contraceptives that contain small amounts of hormones, small fluid-filled cysts called functional ovarian cysts may develop in the ovaries. They usually disappear on their own. In some cases, they may cause mild abdominal pain. Rarely, they may require surgical intervention.
Pregnancy
Before taking any medicine, consult your doctor or pharmacist.
Do not take Lemena if you are pregnant or think you may be pregnant.
Breastfeeding
Before taking any medicine, consult your doctor or pharmacist.
Lemena can be used during breastfeeding. It does not seem to affect milk production or quality. However, a decrease in milk production has been reported in some cases during treatment with Lemena. A small amount of the active substance of Lemena is excreted in breast milk.
The health of children breastfed for 7 months by mothers taking Lemena was studied up to the age of 2.5 years. No effect on growth and development was found in the observed children.
It has not been found that Lemena affects alertness or concentration.
The medicine contains lactose monohydrate (milk sugar) and soybean oil.
If you have been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine.
Do not take the medicine if you are allergic to peanuts or soy.
During treatment with Lemena, your doctor will recommend regular check-ups. The frequency and nature of these check-ups will depend on your individual characteristics.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
The pack contains 28 tablets.
If you do not have a break in taking the pills, vaginal ring, or transdermal patch:
If the delay in taking a pill is less than 12 hours:
If the delay in taking a pill is more than 12 hours:
If you vomit or take activated charcoal within 3-4 hours of taking a tablet of Lemena, or if you experience severe diarrhea, there is a risk that the active substance will not be fully absorbed. Follow the instructions for missing a pill, as described above.
There are no reports of serious harmful effects from taking too many Lemena tablets at once. Symptoms that may occur include nausea, vomiting, and vaginal bleeding in young girls. For further information, consult your doctor.
You can stop taking Lemena at any time. From the day you stop taking Lemena, you are no longer protected against pregnancy.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, Lemena can cause side effects, although not everybody gets them.
Tell your doctor if you notice any side effects, especially if they are severe or persistent.
Serious side effects associated with Lemena have been described in section 2.
For more information, read the subsections "Breast cancer", "Venous thromboembolic disease", and "When not to take Lemena". Read this section carefully, and if necessary, consult your doctor immediately.
While taking Lemena, vaginal bleeding may occur at irregular intervals (see section 2).
Common(may affect up to 1 in 10 people):
mood changes, depression, decreased libido, headaches, nausea, acne, breast pain, irregular bleeding or absence of bleeding, weight gain.
Uncommon(may affect up to 1 in 100 people):
vaginitis, intolerance to contact lenses, vomiting, hair loss, painful bleeding, ovarian cysts, fatigue.
Rare(may affect up to 1 in 1,000 people):
rash, hives, painful red lumps on the skin (erythema nodosum).
In addition to the above side effects, breast discharge or leakage may occur. You should contact your doctor immediately if you experience symptoms of angioedema, such as:
If you experience any side effects, including any not listed in this leaflet, tell your doctor, pharmacist, or nurse. You can also report side effects directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309,
website: https://smz.ezdrowie.gov.pl
You can also report side effects to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
There are no special storage instructions for this medicine.
Do not use this medicine after the expiry date which is stated on the packaging after "EXP".
The expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is desogestrel (75 micrograms).
The other ingredients are lactose monohydrate, cornstarch, povidone K30, d-α-tocopherol (E 307), soybean oil, colloidal silicon dioxide, anhydrous colloidal silicon dioxide, stearic acid, hypromellose 2910, macrogol 400, titanium dioxide (E 171)
One blister pack of Lemena contains 28 white, round, coated tablets.
Each pack contains 1 or 3 PVC/PVDC/Aluminum blisters. The blisters may be placed in a storage case.
Not all pack sizes may be marketed.
Aristo Pharma Sp. z o.o.
Baletowa Street 30
02-867 Warsaw
Laboratorios León Farma, S.A.
C/ La Vallina s/n, Poligono Industrial Navatejera
Villaquilambre, 24193 León
Spain
Date of last revision of the leaflet: October 2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.